190 related articles for article (PubMed ID: 28682562)
1. [Renal diseases related to MYH9 disorders].
Galeano D; Zanoli L; L'Imperio V; Fatuzzo P; Granata A
G Ital Nefrol; 2017 Apr; 34(2):40-57. PubMed ID: 28682562
[TBL] [Abstract][Full Text] [Related]
2. Renal Biopsy-induced Hematoma and Infection in a Patient with Asymptomatic May-Hegglin Anomaly.
Matsumoto T; Yanagihara T; Yoshizaki K; Tsuchiya M; Terasaki M; Nagahama K; Shimizu A; Kunishima S; Maeda M
J Nippon Med Sch; 2021 Dec; 88(6):579-584. PubMed ID: 33692298
[TBL] [Abstract][Full Text] [Related]
3. Nonmuscle Myosin Heavy Chain IIA Mutation Predicts Severity and Progression of Sensorineural Hearing Loss in Patients With MYH9-Related Disease.
Verver EJ; Topsakal V; Kunst HP; Huygen PL; Heller PG; Pujol-Moix N; Savoia A; Benazzo M; Fierro T; Grolman W; Gresele P; Pecci A
Ear Hear; 2016; 37(1):112-20. PubMed ID: 26226608
[TBL] [Abstract][Full Text] [Related]
4. Successful renal transplantation in MYH9-related disorder with severe macrothrombocytopenia: first report in Korea.
Min SY; Ahn HJ; Park WS; Kim JW
Transplant Proc; 2014; 46(2):654-6. PubMed ID: 24656038
[TBL] [Abstract][Full Text] [Related]
5. MYH9 Associated nephropathy.
Furlano M; Arlandis R; Venegas MDP; Novelli S; Crespi J; Bullich G; Ayasreh N; Remacha Á; Ruiz P; Lorente L; Ballarín J; Matamala A; Ars E; Torra R
Nefrologia (Engl Ed); 2019; 39(2):133-140. PubMed ID: 30471777
[TBL] [Abstract][Full Text] [Related]
6. Patients with Epstein-Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease.
Sekine T; Konno M; Sasaki S; Moritani S; Miura T; Wong WS; Nishio H; Nishiguchi T; Ohuchi MY; Tsuchiya S; Matsuyama T; Kanegane H; Ida K; Miura K; Harita Y; Hattori M; Horita S; Igarashi T; Saito H; Kunishima S
Kidney Int; 2010 Jul; 78(2):207-14. PubMed ID: 20200500
[TBL] [Abstract][Full Text] [Related]
7. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness.
Seri M; Pecci A; Di Bari F; Cusano R; Savino M; Panza E; Nigro A; Noris P; Gangarossa S; Rocca B; Gresele P; Bizzaro N; Malatesta P; Koivisto PA; Longo I; Musso R; Pecoraro C; Iolascon A; Magrini U; Rodriguez Soriano J; Renieri A; Ghiggeri GM; Ravazzolo R; Balduini CL; Savoia A
Medicine (Baltimore); 2003 May; 82(3):203-15. PubMed ID: 12792306
[TBL] [Abstract][Full Text] [Related]
8. MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations.
Pecci A; Klersy C; Gresele P; Lee KJ; De Rocco D; Bozzi V; Russo G; Heller PG; Loffredo G; Ballmaier M; Fabris F; Beggiato E; Kahr WH; Pujol-Moix N; Platokouki H; Van Geet C; Noris P; Yerram P; Hermans C; Gerber B; Economou M; De Groot M; Zieger B; De Candia E; Fraticelli V; Kersseboom R; Piccoli GB; Zimmermann S; Fierro T; Glembotsky AC; Vianello F; Zaninetti C; Nicchia E; Güthner C; Baronci C; Seri M; Knight PJ; Balduini CL; Savoia A
Hum Mutat; 2014 Feb; 35(2):236-47. PubMed ID: 24186861
[TBL] [Abstract][Full Text] [Related]
9. Management of patients with severe Epstein syndrome: Review of four patients who received living-donor renal transplantation.
Hashimoto J; Hamasaki Y; Takahashi Y; Kubota M; Yanagisawa T; Itabashi Y; Muramatsu M; Kawamura T; Kumagai N; Ohwada Y; Sakai K; Shishido S
Nephrology (Carlton); 2019 Apr; 24(4):450-455. PubMed ID: 29532554
[TBL] [Abstract][Full Text] [Related]
10. Macrothrombocytopenia, renal dysfunction and nephrotic syndrome in a young male patient: a case report of MYH9-related disease.
Sevignani G; Pavanelli GM; Milano SS; Ferronato BR; Pachaly MA; Ii Cheong H; Carvalho M; Barreto FC
J Bras Nefrol; 2018; 40(2):198-200. PubMed ID: 29782633
[TBL] [Abstract][Full Text] [Related]
11. Renal manifestations of patients with MYH9-related disorders.
Han KH; Lee H; Kang HG; Moon KC; Lee JH; Park YS; Ha IS; Ahn HS; Choi Y; Cheong HI
Pediatr Nephrol; 2011 Apr; 26(4):549-55. PubMed ID: 21210153
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of
Rabbolini DJ; Chun Y; Latimer M; Kunishima S; Fixter K; Valecha B; Tan P; Chew LP; Kile BT; Burt R; Radhakrishnan K; Bird R; Ockelford P; Gabrielli S; Chen Q; Stevenson WS; Ward CM; Morel-Kopp MC
Platelets; 2018 Dec; 29(8):793-800. PubMed ID: 29090586
[No Abstract] [Full Text] [Related]
13. Congenital thrombocytopenia with nephritis - The first case of MYH9 related disorder in Serbia.
Kuzmanović M; Kunishima S; Putnik J; Stajić N; Paripović A; Bogdanović R
Vojnosanit Pregl; 2014 Apr; 71(4):395-8. PubMed ID: 24783421
[TBL] [Abstract][Full Text] [Related]
14. Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease.
Pecci A; Panza E; Pujol-Moix N; Klersy C; Di Bari F; Bozzi V; Gresele P; Lethagen S; Fabris F; Dufour C; Granata A; Doubek M; Pecoraro C; Koivisto PA; Heller PG; Iolascon A; Alvisi P; Schwabe D; De Candia E; Rocca B; Russo U; Ramenghi U; Noris P; Seri M; Balduini CL; Savoia A
Hum Mutat; 2008 Mar; 29(3):409-17. PubMed ID: 18059020
[TBL] [Abstract][Full Text] [Related]
15. Severe to profound deafness may be associated with MYH9-related disease: report of 4 patients.
Canzi P; Pecci A; Manfrin M; Rebecchi E; Zaninetti C; Bozzi V; Benazzo M
Acta Otorhinolaryngol Ital; 2016 Oct; 36(5):415-420. PubMed ID: 27958602
[TBL] [Abstract][Full Text] [Related]
16. Linking the Landscape of
Asensio-Juárez G; Llorente-González C; Vicente-Manzanares M
Cells; 2020 Jun; 9(6):. PubMed ID: 32545517
[TBL] [Abstract][Full Text] [Related]
17. MYH9-Related Thrombocytopenia: Four Novel Variants Affecting the Tail Domain of the Non-Muscle Myosin Heavy Chain IIA Associated with a Mild Clinical Evolution of the Disorder.
Zaninetti C; De Rocco D; Giangregorio T; Bozzi V; Demeter J; Leoni P; Noris P; Ryhänen S; Barozzi S; Pecci A; Savoia A
Hamostaseologie; 2019 Feb; 39(1):87-94. PubMed ID: 29996171
[TBL] [Abstract][Full Text] [Related]
18. Cloning of the murine non-muscle myosin heavy chain IIA gene ortholog of human MYH9 responsible for May-Hegglin, Sebastian, Fechtner, and Epstein syndromes.
D'Apolito M; Guarnieri V; Boncristiano M; Zelante L; Savoia A
Gene; 2002 Mar; 286(2):215-22. PubMed ID: 11943476
[TBL] [Abstract][Full Text] [Related]
19. Late onset and high-frequency dominant hearing loss in a family with MYH9 disorder.
Wasano K; Matsunaga T; Ogawa K; Kunishima S
Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3547-3552. PubMed ID: 26942920
[TBL] [Abstract][Full Text] [Related]
20. R705H mutation of MYH9 is associated with MYH9-related disease and not only with non-syndromic deafness DFNA17.
Verver E; Pecci A; De Rocco D; Ryhänen S; Barozzi S; Kunst H; Topsakal V; Savoia A
Clin Genet; 2015 Jul; 88(1):85-9. PubMed ID: 24890873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
